Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Closed-loop vs Sensor-augmented Pump in Type 1 Diabetes (CLASS-13)
NCT02490098Phase 2Withdrawn
- Sponsor
- Montreal Clinical Research Institute
- Start
- Jan 2018
- Primary completion
- Jul 2018
- Modality
- Peptides, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of glucagon in type 1 diabetes mellitus (T1D), sponsored by Montreal Clinical Research Institute. Planned start Jan 2018; status: withdrawn.
02
Drugs
glucagon
03
Conditions
type 1 diabetes mellitus (T1D)
Beyond the preview
Go deeper on NCT02490098.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02490098.